Report of foreign issuer [Rules 13a-16 and 15d-16]

Consolidated Statements of Cash Flows

v3.25.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (85,433) $ (78,340)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 32,029 35,068
Stock-based compensation 17,986 22,564
Foreign currency transaction loss (gain) (8,792) (1,413)
Share in net (profits) losses of associated companies 39,100 1,559
Unrealized Gain (Loss) on Investments 4,235 3,424
Acquisitions 862 1,553
Deferred income taxes, net and uncertain tax positions 460 238
Other non-cash items, net 849 2,751
Change in cash attributable to changes in operating assets and liabilities:    
Accounts receivable, net 953 18,480
Inventories 24,765 171
Other current assets and prepaid expenses (7,582) 6,173
Other non-current assets 7,553 5,257
Accounts payable (7,714) 550
Other current liabilities (4,652) (2,926)
Deferred revenues 408 (7,819)
Other non-current liabilities (4,689) (6,853)
Net cash provided by (used in) operating activities 10,338 437
Cash flows from investing activities    
Cash paid for business combinations (5,448) 0
Purchase of property and equipment (15,487) (6,668)
Investments in short-term bank deposits (223,500) (90,000)
Proceeds from sale of equity method investment 120,500 90,000
Investments in unconsolidated entities (1,557) (8,845)
Purchase of intangible assets (4,389) (1,486)
Other investing activities (550) (176)
Net cash used in investing activities (130,431) (17,175)
Cash flows from financing activities    
Proceeds from exercise of stock options 0 153
Payment of contingent consideration (951) (1,302)
Proceeds from PIPE transaction, net of issuance costs 119,291 0
Other financing activities (57) 33
Net cash provided by (used in) financing activities 118,283 (1,116)
Effect of exchange rate changes on cash, cash equivalents and restricted cash 3,049 (178)
Net change in cash, cash equivalents and restricted cash 1,239 (18,032)
Cash, cash equivalents and restricted cash, beginning of year 71,076 82,864
Cash, cash equivalents and restricted cash, end of year 72,315 64,832
Non-cash investing and financing activities:    
Transfer of inventories to fixed assets 3,236 1,850
Transfer of fixed assets to inventories 22 4,829
Issuance of ordinary shares under employee share purchase plan 2,598 3,264
Issuance of ordinary shares as part of Nexa3D Inc. transaction 3,135 0
Reconciliation of cash, cash equivalents and restricted cash reported in the consolidated balance sheets:    
Cash and cash equivalents 71,470 63,956
Restricted cash included in other current assets 845 876
Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows $ 72,315 $ 64,832